Search
MD · Company research

Pediatrix Medical Group, Inc. (MD): Stock News & Events

Recent company-linked news records available in the database.

Main stock researchCompare stocks
RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

22records availableHealthcare

Stock News & Events data

Database-backed records only

22 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
A doctor with more than 20 years in biopharma leadership and finance will lead Actinium's finances. - Stock TitanA doctor with more than 20 years in biopharma leadership and finance will lead Actinium's finances. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
Pediatrix Medical Group, Inc. (MD) Stock forecasts - Yahoo Finance UKPediatrix Medical Group, Inc. (MD) Stock forecasts Yahoo Finance UKView source ↗Yahoo Finance UKOct 15, 2026neutral00.6
Nakamoto (Nasdaq:NAKA) - Stock Analysis - Simply Wall StreetNakamoto (Nasdaq:NAKA) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 15, 2026neutral00.6
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo FinancePediatrix Medical Group, Inc. (MD) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 15, 2026neutral00.6
3 Reasons MD is Risky and 1 Stock to Buy Instead - Yahoo Finance3 Reasons MD is Risky and 1 Stock to Buy Instead Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
3 Reasons MD is Risky and 1 Stock to Buy Instead - FinancialContent3 Reasons MD is Risky and 1 Stock to Buy Instead FinancialContentView source ↗FinancialContentOct 14, 2026neutral00.6
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-TermPediatrix Medical Group (MD) is highlighted as a potential growth stock with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 13.7% for fiscal 2026, a B Growth Style Score, and a positive average earnings surprise of +17.4%. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $2.32 per share.View source ↗Zacks Investment ResearchOct 9, 2026bullish11
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-TermPediatrix Medical Group (MD) is highlighted as a potential growth stock with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 13.7% for fiscal 2026, a B Growth Style Score, and a positive average earnings surprise of +17.4%. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $2.32 per share.View source ↗Zacks Investment ResearchOct 9, 2026bullish11
MD, CEO & Director of Prospect Resources Picks Up 4.0% More Stock - Simply Wall StreetMD, CEO & Director of Prospect Resources Picks Up 4.0% More Stock Simply Wall StreetView source ↗Simply Wall StreetOct 8, 2026neutral00.6
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo FinancePediatrix Medical Group, Inc. (MD) Stock Forecasts Yahoo FinanceView source ↗Yahoo FinanceOct 8, 2026neutral00.6
Fundstrat MD Mark Newton covers stock market chart patterns post inflation data - qz.comFundstrat MD Mark Newton covers stock market chart patterns post inflation data qz.comView source ↗qz.comOct 2, 2026neutral00.6
3 Healthcare Stocks That Concern Us - Yahoo Finance3 Healthcare Stocks That Concern Us Yahoo FinanceView source ↗Yahoo FinanceSep 30, 2026neutral00.6
Columbia Financial (CLBK) CEO boosts deferred stock stake - Stock TitanColumbia Financial (CLBK) CEO boosts deferred stock stake Stock TitanView source ↗Stock TitanSep 22, 2026neutral00.6
Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback - Yahoo FinancePediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback Yahoo FinanceView source ↗Yahoo FinanceSep 21, 2026neutral00.6
Mfazo Hove, MD, shares his own experience with a trifocal IOL, two and a half years after cataract surgery - Ophthalmology TimesMfazo Hove, MD, shares his own experience with a trifocal IOL, two and a half years after cataract surgery Ophthalmology TimesView source ↗Ophthalmology TimesSep 16, 2026neutral00.6
Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety - ChartMillPediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety ChartMillView source ↗ChartMillAug 15, 2026neutral00.6
Stock Epinephrine Could Close Anaphylaxis Care Gap, With Jay Lieberman, MD - HCPLiveStock Epinephrine Could Close Anaphylaxis Care Gap, With Jay Lieberman, MD HCPLiveView source ↗HCPLiveAug 13, 2026neutral00.6
Pediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions - Simply Wall StreetPediatrix Medical Group (MD) Stock Seems Undervalued While Its 89% Return Raises Questions Simply Wall StreetView source ↗Simply Wall StreetAug 9, 2026neutral00.6
Pediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3% - StockStoryPediatrix Medical Group’s (NYSE:MD) Q2 CY2026: Beats On Revenue But Stock Drops 12.3% StockStoryView source ↗StockStoryAug 4, 2026neutral00.6
MEDNAX ($MD) Releases Q2 2026 Earnings | MD Stock News - Quiver QuantitativeMEDNAX ($MD) Releases Q2 2026 Earnings | MD Stock News Quiver QuantitativeView source ↗Quiver QuantitativeAug 4, 2026neutral00.6
Pediatrix Medical Group (NYSE:MD): A Decent Value Stock at a Discount - ChartMillPediatrix Medical Group (NYSE:MD): A Decent Value Stock at a Discount ChartMillView source ↗ChartMillJul 24, 2026neutral00.6
3 Reasons MD is Risky and 1 Stock to Buy Instead - Yahoo Finance3 Reasons MD is Risky and 1 Stock to Buy Instead Yahoo FinanceView source ↗Yahoo FinanceApr 20, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.